Fax: (703) 413-8111
Version of Record online: 5 JUL 2011
Copyright © 2011 American Cancer Society
Volume 117, Issue 24, pages 5560–5568, 15 December 2011
How to Cite
Anhang Price, R., Tiro, J. A., Saraiya, M., Meissner, H. and Breen, N. (2011), Use of human papillomavirus vaccines among young adult women in the United States: An analysis of the 2008 National Health Interview Survey. Cancer, 117: 5560–5568. doi: 10.1002/cncr.26244
We gratefully acknowledge Charlene Wong for her comments on an earlier draft of the manuscript, and Tim McNeel and Will Waldron of Information Management Services, Inc. for their programming support.
Rebecca Anhang Price prepared this manuscript while an SAIC-Frederick, Inc. contractor to the Applied Cancer Screening Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland.
The findings and conclusions in this report are those of the authors and do not necessarily reflect the official position of the Department of Health and Human Services, the National Institutes of Health, the Centers for Disease Control and Prevention, or the US Government, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government.
- Issue online: 2 DEC 2011
- Version of Record online: 5 JUL 2011
- Manuscript Accepted: 12 JAN 2011
- Manuscript Received: 18 NOV 2010
- human papillomavirus;
- cervical cancer;
The Centers for Disease Control and Prevention recommends catch-up administration of human papillomavirus (HPV) vaccines to girls and women ages 13 to 26 who have not been vaccinated previously. In response to debate regarding catch-up vaccination of young adult women, this study examined whether 18- to 26-year-old women most likely to benefit from catch-up vaccination were aware of the HPV vaccine, and initiated the vaccine series by the end of 2008.
We used data from the 2008 National Health Interview Survey to assess HPV vaccine awareness and use, and reasons for not vaccinating, among women aged 18-26 years (n = 1583). Sociodemographic, health care access, and health history factors associated with vaccine initiation were assessed using multivariate logistic regression.
Overall, 11.7% of women aged 18-26 years reported receiving at least 1 dose of the HPV vaccine by the end of 2008. In multivariate analyses, younger age, history of previous HPV infection, unmarried status, health insurance, flu shot in the past year, and receipt of 1 or more recommended lifetime vaccines were significantly associated with HPV vaccine initiation. Two-fifths (39.6%) of unvaccinated women were interested in receiving the HPV vaccine (n = 1327). Primary reasons for lack of interest in the vaccine were belief that it was not needed, not knowing enough about it, concerns about safety, and not being sexually active.
HPV vaccine coverage among young adult women was low, and lower among the uninsured than the insured. Public financing and care provision programs have the potential to expand vaccine coverage among uninsured women, who are at increased risk of cervical cancer. Cancer 2011;. © 2011 American Cancer Society.